Compare HCWB & BLIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HCWB | BLIN |
|---|---|---|
| Founded | 2018 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.8M | 14.6M |
| IPO Year | 2021 | 2018 |
| Metric | HCWB | BLIN |
|---|---|---|
| Price | $3.26 | $1.13 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $35.00 | $4.62 |
| AVG Volume (30 Days) | ★ 61.4K | 52.1K |
| Earning Date | 05-15-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.37 | N/A |
| Revenue | $4,099,750.00 | ★ $13,568,000.00 |
| Revenue This Year | N/A | $22.67 |
| Revenue Next Year | N/A | $21.08 |
| P/E Ratio | $9.14 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.25 | $0.69 |
| 52 Week High | $7.35 | $1.59 |
| Indicator | HCWB | BLIN |
|---|---|---|
| Relative Strength Index (RSI) | 52.15 | 44.01 |
| Support Level | $0.37 | $0.93 |
| Resistance Level | $4.00 | $1.15 |
| Average True Range (ATR) | 0.44 | 0.07 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 50.53 | 33.76 |
HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that it believes has the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. The company has developed two proprietary drug discovery and development platforms which it uses to create novel fusion immunotherapeutics: The TOBI (Tissue factOr-Based fusIon) platform, and The T-cell Receptor Beta Chain constant region (TRBC) platform. It operates and manages its business as one reportable segment.
Bridgeline Digital Inc is a AI-powered marketing technology company that offers a suite of products that help companies grow online revenue by driving more traffic to their websites, converting more visitors to purchasers, and increasing average order value. Company software is available through a cloud-based Software as a Service (SaaS) model. It helps to maximize the performance of critical websites, intranets, and online stores. The company generates revenue from digital engagement services, subscription, perpetual licenses, maintenance, and hosting. Geographically, it derives a majority of revenue from the United States.